Search results
Results From The WOW.Com Content Network
Acquisition offer by Boston Scientific [ edit ] On December 5, 2005, Boston Scientific made a surprise unsolicited $24.6 billion bid to acquire Guidant, offering $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share.
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
BTG plc completed the acquisition of Protherics PLC in December 2008 and of Biocompatibles International plc in January 2011. [8] In May 2016 BTG plc acquired the Israeli company Galil Medical for US$110 million. [9] In September 2018, BTG plc acquired Novate Medical for up to $150 million. [10]
For premium support please call: 800-290-4726 more ways to reach us
Boston Scientific forecast a full-year profit on Wednesday that was largely ahead of analysts' estimates and said the U.S. health regulator has approved its heart device, sending the company's ...
With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share).
They borrowed $800,000 to start Boston Scientific, a manufacturer of medical devices. He helped grow the company through a series of astute acquisitions. [6] Nicholas was chief executive officer of the company until 1999, when he became chairman. He continued in that role until his retirement in 2016. [3]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Boston_Scientific_Corporation&oldid=19811070"